Engineering Enzyme-Cleavable Oligonucleotides by Automated Solid-Phase Incorporation of Cathepsin B Sensitive Dipeptide Linkers. (2022)
Attributed to:
Advancing Oligonucleotide Therapeutics
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/ange.202114016
PubMed Identifier: 38505643
Publication URI: http://europepmc.org/abstract/MED/38505643
Type: Journal Article/Review
Volume: 134
Parent Publication: Angewandte Chemie (Weinheim an der Bergstrasse, Germany)
Issue: 13
ISSN: 0044-8249